PDL-1 assay concordance
20 Oct 2016
PDL-1 assay concordance
CDK4/6 inhibitors for metastatic breast cancer
TRAIL induced apoptosis for cancer stem cells
Carcinoid syndrome
Who should receive combination therapy for ER positive breast cancer?
Positive lessons of negative trials
Drug repurposing of propranolol
ESMO 2016 conference highlights
Risk of serious and fatal adverse events with sorafenib use in patients with solid cancers
Oncolytic virotherapy using coxsackie virus
Monitoring patterns of care in mCRPC patients with the help of the Cancer Registry
Lurbinectedin in BRCA 1/2 breast cancer